Youtor
Icml Lugano (updated 2024-10-09)
![An update in Lymphoma Including Best of 16th ICML Lugano Day 7 [upl. by Atilehs]](img.php?img=imgidYAhnxE66HtU)
Duration: 3:39:26
161 weergaven | 24 sep. 2021
161 weergaven | 24 sep. 2021
![Highlights from ICML 2017 The CLL2BAG study [upl. by Hannasus]](img.php?img=imgid_6zEh1dRlxE)
![Providing a PLATFORM first results for lisocel plus durvalumab in RR Bcell NHL [upl. by Inaja]](img.php?img=imgido_3-EmETmfQ)
Duration: 3:23
116 weergaven | 19 jul. 2019
116 weergaven | 19 jul. 2019
![The possibility of moving away from radiation therapy in pediatric patients with Hodgkin lymphoma [upl. by Niamart]](img.php?img=imgidOLQgTxLx1aA)
Duration: 1:17
136 weergaven | 31 jul. 2023
136 weergaven | 31 jul. 2023
![Current state of the field noncovalent BTK inhibitors for CLL [upl. by Artus]](img.php?img=imgid157fCx_zgbg)
Duration: 1:07
109 weergaven | 14 jun. 2023
109 weergaven | 14 jun. 2023
![Improving MRD assessment and response criteria in DLBCL insights into PhasEDSeq [upl. by Nored]](img.php?img=imgidp6lzuMldfIo)
Duration: 1:21
369 weergaven | 25 jul. 2023
369 weergaven | 25 jul. 2023
![SUNMO mosunetuzumab polatuzumab vedotin vs RGemOx in RR aggressive NHL [upl. by Eceertal691]](img.php?img=imgidyqupmcGWNQ8)
Duration: 0:49
146 weergaven | 1 aug. 2023
146 weergaven | 1 aug. 2023
![Using GEP to molecularly characterize amp predict the outcomes of patients with PMBCL [upl. by Ecirtel881]](img.php?img=imgidFzwgD-wt4FA)
Duration: 2:15
55 weergaven | 23 jun. 2023
55 weergaven | 23 jun. 2023
![Work of the Follicular Lymphoma Foundation [upl. by Mayman]](img.php?img=imgidaHYBB1MNgfo)
![OLYMPIA5 odronextamab lenalidomide for RR indolent lymphoma [upl. by Dyob]](img.php?img=imgidguWGlWHR0cg)
Duration: 1:21
189 weergaven | 21 jul. 2023
189 weergaven | 21 jul. 2023
![Follicular lymphoma the value of immunotherapies amp other exciting areas of research [upl. by Ynatil544]](img.php?img=imgidJLpUUrfc2BI)
Duration: 1:52
906 weergaven | 1 aug. 2023
906 weergaven | 1 aug. 2023
![Chemofree in CLL not always the best option [upl. by Clorinda]](img.php?img=imgidf9modP2hnVU)
![The importance of understanding the TME amp using this to guide treatment for Bcell lymphomas [upl. by Ronnica783]](img.php?img=imgidpW18zDyVgBE)
Duration: 1:32
349 weergaven | 11 jul. 2023
349 weergaven | 11 jul. 2023
![Promising CLL amp FL data from ICML 2017 BGB3111 and obinituzumab [upl. by Daisy]](img.php?img=imgidSR3pE8Up0Wk)
Duration: 3:22
541 weergaven | 21 jun. 2017
541 weergaven | 21 jun. 2017
![DLBCL research to watch [upl. by Weinberg]](img.php?img=imgidWdfgWNzG_EI)
![Outcomes of patients with DLBCL following ASCT andor CART [upl. by Kuebbing]](img.php?img=imgidL-emdXr4PoI)
Duration: 1:50
269 weergaven | 14 jun. 2023
269 weergaven | 14 jun. 2023
![Agressive or transformed MCL prognostic factors outcomes amp mutational profile [upl. by Nylicaj]](img.php?img=imgidzO_6nr_OSYM)
Duration: 2:18
334 weergaven | 2 jul. 2019
334 weergaven | 2 jul. 2019
![Linfomi nonHodgkin nuovi dati promettenti sul bispecifico glofitamab da solo o in combinazione [upl. by Avrit]](img.php?img=imgidiBkr5AmWow0)
Duration: 10:02
1,9K weergaven | 13 jul. 2023
1,9K weergaven | 13 jul. 2023
![Intratumoral CpG ibrutinib and radiotherapy in lowgrade RR follicular lymphoma [upl. by Woothen]](img.php?img=imgidv13ciSpVyeU)
Duration: 2:21
582 weergaven | 2 jul. 2019
582 weergaven | 2 jul. 2019
![IR plus RHCVADRMTX efficacious for young MCL in the firstline [upl. by Roth]](img.php?img=imgid744H1AOiHis)
Duration: 1:03
84 weergaven | 2 jul. 2019
84 weergaven | 2 jul. 2019
![Fixedduration treatment strategies for frontline and relapsed CLL [upl. by Eniledgam]](img.php?img=imgidZteeS0JSoKU)
Duration: 0:56
165 weergaven | 28 jul. 2023
165 weergaven | 28 jul. 2023
![Smart Start for newly diagnosed DLBCL rituximablenalidomideibrutinib [upl. by Anat]](img.php?img=imgidvK_RQy4mOqM)
Duration: 1:44
315 weergaven | 28 jun. 2019
315 weergaven | 28 jun. 2019
![Using models to predict progression in follicular lymphoma [upl. by Idoc]](img.php?img=imgidhDE1aGBSMFs)
Duration: 1:01
260 weergaven | 6 jul. 2017
260 weergaven | 6 jul. 2017
![Loncastuximab tesirine longterm survival data from LOTIS2 amp insights into the LOTIS7 trial [upl. by Sankey]](img.php?img=imgidJ1OSZA2UHpQ)
Duration: 1:09
177 weergaven | 2 aug. 2023
177 weergaven | 2 aug. 2023
![Dutch HOVON lymphoma study group update [upl. by Aztinad]](img.php?img=imgidUmyQA3I9Azs)
![Treatment of aggressive NHL in frail patients cardiac comorbidities and advanced age [upl. by Nylanej478]](img.php?img=imgid0rV94GPKsIo)
Duration: 2:07
68 weergaven | 1 jul. 2019
68 weergaven | 1 jul. 2019
![ALPINE results zanubrutinib vs ibrutinib in CLL [upl. by Xyno]](img.php?img=imgidMcOB6E2YjQk)
![FC LUGANO 34 FENERBAHÇE Geniş Maç Özeti Şampiyonlar Ligi 2 Ön Eleme Turu İlk Maçı [upl. by Byram]](img.php?img=imgidRAa6kbVPXZM)
Duration: 10:32
1,3mln. weergaven | 2 maanden geleden
1,3mln. weergaven | 2 maanden geleden
![CLL14 venetoclaxobinutuzumab improves PFS and MRD in untreated reduced fitness CLL [upl. by Banky]](img.php?img=imgidL_ymRM-rls8)
Duration: 1:16
279 weergaven | 20 jun. 2019
279 weergaven | 20 jun. 2019
![Differences between NLPHL and classical HL amp promising treatment approaches for NLPHL [upl. by Torosian]](img.php?img=imgidk2QkriYBpUY)
Duration: 1:25
533 weergaven | 27 jul. 2023
533 weergaven | 27 jul. 2023
